News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Sponsored Content
Drug Development
Jubilant’s Precision Medicines Offer Safety, Therapeutic Advantages in Cancer, Immunology
Jubilant Therapeutics’ differentiated, orally bioavailable molecules address both validated and novel therapeutic targets in oncology and immunology.
June 14, 2023
·
7 min read
·
Sponsored Content
Business
Sponsored: Inspirational Space Sparks Scientific Innovation at the First Life Sciences Building in Chicago’s Lincoln Yards
Real estate development firm Sterling Bay launches life sciences division starting with Lincoln Yards, a 320,000 square foot site on the Chicago River.
March 16, 2023
·
10 min read
·
Sponsored Content
Sponsored: Are You Looking for a Long-Term Partnership for Your Next OEM Project? Trust Our Expertise
Discover how Eppendorf OEM worked with the market leader in laboratory automation to develop a win-win business model and 25-year partnership.
November 9, 2022
·
1 min read
·
Sponsored Content
SPONSORED: Taking the Headache out of Unpredictable Production Requirements with Scalable Solutions
Discover how Eppendorf OEM worked with the market leader in laboratory automation to develop a win-win business model and 25-year partnership.
July 8, 2022
·
1 min read
·
Sponsored Content
